Insider: Wong Hing C Chief Executive Officer - HCW Biologics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 501,911 | 0 | 501,911 |
| Value | $2,042,777.77 | $0.00 | $2,042,777.77 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/16/2025 | AAP | 8,054 | Direct | COM | $7.45 | $60,002.30 | 501,911 |
| 05/08/2025 | AAP | 92,500 | Direct | COM | $26.00 | $2,405,000.00 | 493,857 |
| 09/14/2023 | AAP | 1,800 | Direct | COM | $2.08 | $3,740.76 | 15,314,868 |
| 06/02/2023 | AAP | 800 | Direct | COM | $1.54 | $1,228.24 | 15,313,068 |
| 06/01/2023 | AAP | 800 | Direct | COM | $1.62 | $1,294.24 | 15,312,268 |
| 05/31/2023 | AAP | 2,000 | Direct | COM | $1.55 | $3,092.00 | 15,311,468 |
| 05/30/2023 | AAP | 3,000 | Direct | COM | $1.55 | $4,658.10 | 15,309,468 |
| 09/09/2022 | AAP | 6,000 | Direct | COM | $2.70 | $16,200.00 | 15,306,468 |
| 09/08/2022 | AAP | 4,000 | Direct | COM | $2.67 | $10,680.00 | 15,300,468 |
| 09/07/2022 | AAP | 6,000 | Direct | COM | $2.58 | $15,480.00 | 15,296,468 |
| 09/02/2022 | AAP | 4,000 | Direct | COM | $2.55 | $10,200.00 | 15,290,468 |
| 06/10/2022 | AAP | 1,520 | Direct | COM | $2.19 | $3,325.76 | 15,286,468 |
| 08/31/2021 | AAP | 3,830 | Direct | COM | $3.93 | $15,070.28 | 15,277,948 |
| 08/30/2021 | AAP | 6,000 | Direct | COM | $3.93 | $23,599.80 | 15,274,118 |
| 08/27/2021 | AAP | 6,000 | Direct | COM | $3.77 | $22,620.00 | 15,268,118 |
| 08/26/2021 | AAP | 6,500 | Direct | COM | $3.84 | $24,969.75 | 15,262,118 |
| 07/22/2021 | AAP | 627,500 | Direct | COM | $8.00 | $5,020,000.00 | 15,255,618 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research